An update on autoinflammatory diseases

Current Medicinal Chemistry

Volumn 21, Issue 3, 2014, Pages 261-269

  Ciccarelli, F ^a   De Martinis, M ^a   Ginaldi, L ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Auto inflammation; Chronic inflammatory diseases; Innate immunity

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADULT ONSET STILL DISEASE; ARTICLE; AUTOINFLAMMATORY DISEASE; BEHCET DISEASE; BLAU SYNDROME; CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS; CINCA SYNDROME; CROHN DISEASE; DEFICIT OF INTERLEUKIN 1 RECEPTOR ANTAGONIST; DISEASE ASSOCIATION; FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; FAMILIAL MEDITERRANEAN FEVER; HUMAN; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; INFLAMMATION; JUVENILE RHEUMATOID ARTHRITIS; LYMPHADENOPATHY; MAJEED SYNDROME; MUCKLE WELLS SYNDROME; OSTEOMYELITIS; PAPA SYNDROME; PFAPA SYNDROME; RASH; RECURRENT FEVER; SAPHO SYNDROME; SCHNITZLER SYNDROME; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; IMMUNITY, INNATE; INFLAMMATION; T-LYMPHOCYTES;

EID: 84893209076     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/09298673113206660303     Document Type: Article

References (56)

1. McDermott, M.F.; Aksentijevich, I.; Galon, J.; McDermott, E.M.; Ogunkolade, B.W.; Centola, M.; Mansfield, E.; Gadina, M.; Karenko, L.; Pettersson, T.; McCarthy, J.; Frucht, D.M.; Aringer, M.; Torosyan, Y.; Teppo, A.M.; Wilson, M.; Karaarslan, H.M.; Wan, Y.; Todd, I.; Wood, G.; Schlimgen, R.; Kumarajeewa, T.R.; Cooper, S.M.; Vella, J.P.; Amos, C.I.; Mulley, J.; Quane, K.A.; Molloy, M.G.; Ranki, A.; Powell, R.J.; Hitman, G.A.; O'Shea, J.J.; Kastner, D.L. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell, 1999, 97(1), 133-144.
2. Ginaldi, L.; Di Benedetto, M.C.; De Martinis, M. Osteoporosis, inflammation and ageing. Immun. Ageing., 2005, 2, 14.
3. Franceschi, C.; Bonafe, M.; Valensin, S.; Olivieri, F.; De Luca, M.; Ottaviani, E.; De Benedictis, G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. USA, 2000, 908, 244-254.
4. Salminen, A.; Kaarniranta, K.; Kauppinen, A. Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging, 2012, 4(3), 166-175.
5. Folashade, A.J.; Melvin, B.H. Extraintestinal manifestations of Inflammatory Bowel Disease. J. Pediatr. Gastroenterol. Nutr., 2008, 46(2), 124-133.
6. Dinarello, C.A.; Wolff, S.M.; Goldfinger, S.E.; Dale, D.C.; Alling, D.W. Colchicine therapy for familial mediterranean fever. A double- blind trial. N. Engl. J. Med., 1974, 291, 934.
7. Simon, A.; Cuisset, L.; Vincent, M.F.; van Der Velde-Visser, S.D.; Delpech, M.; van Der Meer, J.W.; Drenth, J.P. Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper- Igd and periodic fever syndrome: its application as a diagnostic tool. Ann. Intern. Med., 2001, 135(5), 338-343.
8. Goldfinger, S. The inherited autoinflammatory syndrome:a decade of discovery. Trans. Am. Clin. Climatol. Assoc., 2009, 120, 413-418.
9. Cailliez, M.; Garaix, F.; Rousset-Rouviere, C.; Bruno, D.; Kone-Paut, I.; Sarles, J. Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis. J. Inherit. Metab. Dis., 2006, 29(6), 763.
10. Bulua, A.C.; Mogul, D.B.; Aksentijevich, I.; Singh, H.; He, D.; Muenz, L.R.; Ward, M.M.; Yarboro, C.H.; Kastner, D.L.; Siegel, R.M.; Hull, K.M. Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, openlabel, dose-escalation study.. Arthritis Rheum., 2012, 64(3), 908-913.
11. Iacobelli, S.; Andre, M.; Alexandra, J.F.; Dode, C.; Papo, T. Failure of antiTNF therapy in TNF receptor 1 associated periodic syndrome (TRAPS). Rheumatology, 2007, 46, 1211-1212.
12. Gattorno, M.; Pelagatti, M.A.; Meini, A.; Obici, L.; Barcellona, R.; Federici, S. Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum., 2008, 58(5), 1516-1520.
13. Feldmann, J.; Prieur, A.M.; Quartier, P.; Berquin, P.; Certain, S.; Cortis, E. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am. J. Hum. Genet., 2002, 71(1), 198-203.
14. De Sanctis, S.; Nozzi, M.; Del Torto, M.; Scardapane, A.; Gaspari, S.; de Michele, G.; Breda, L.; Chiarelli, F. Autoinflammatory syndromes: diagnosis and management. Ital. J. Pediatr., 2010, 36, 57.
15. Jéru, I.; Duquesnoy, P.; Fernandes-Alnemri, T.; Cochet, E.; Yu, J.W.; Lackmy-Port-Lis, M.; Grimprel, E.; Landman-Parker, J.; Hentgen, V.; Marlin, S.; McElreavey, K.; Sarkisian, T.; Grateau, G.; Alnemri, E.S.; Amselem, S. Mutations in NALP12 cause hereditary periodic fever syndromes. Proc. Natl. Acad. Sci. USA, 2008, 105, 1614-1619.
16. Aksentijevich, I.; Masters, S.L.; Ferguson, P.J.; Dancey, P.; Frenkel, J.; van Royen-Kerkhoff, A.; Laxer, R.; Tedgård, U.; Cowen, E.W.; Pham, T.H.; Booty, M.; Estes, J.D.; Sandler, N.G.; Plass, N.; Stone, D.L.; Turner, M.L.; Hill, S.; Butman, J.A.; Schneider, R.; Babyn, P.; El-Shanti, H.I.; Pope, E.; Barron, K.; Bing, X.; Laurence, A.; Lee, C.C.; Chapelle, D.; Clarke, G.I.; Ohson, K.; Nicholson, M.; Gadina, M.; Yang, B.; Korman, B.D.; Gregersen, P.K.; van Hagen, P.M.; Hak, A.E.; Huizing, M.; Rahman, P.; Douek, D.C.; Remmers, E.F.; Kastner, D.L.; Goldbach-Mansky, R. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N. Engl. J. Med., 2009, 360, 2426-2437.
17. Dierselhuis, M.P.; Frenkel, J.; Wulffraat, N.M.; Boelens, J.J. Anakinra for flares of pyogenic arthritis in PAPA syndrome. Rheumatology. (Oxford), 2005, 44(3), 406-408.
18. Majeed, H.A.; Kalaawi, M.; Mohanty, D.; Teebi, A.S.; Tunjekar, M.F.; al-Gharbawy, F.; Majeed, S.A.; al-Gazzar, A.H. Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings. J. Pediatr., 1989, 115(5Pt1), 730-734.
19. Arostegui, J.I.; Arnal, C.; Merino, R.; Modesto, C.; Antonia, C.M.; Moreno, P. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum., 2007, 56(11), 3805-3813.
20. Ogura, Y.; Bonen, D.K.; Inohara, N.; Nicolae, D.L.; Chen, F.F.; Ramos, R.; Britton, H.; Moran, T.; Karaliuskas, R.; Duerr, R.H.; Achkar, J.P.; Brant, S.R.; Bayless, T.M.; Kirschner, B.S.; Hanauer, S.B.; Nuñez, G.; Cho, J.H. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature, 2001, 411(6837), 603-606.
21. Stojanov, S.; Lapidus, S.; Chitkara, P.; Feder, H.; Salazar, J.C.; Fleisher, T.A.; Brown, M.R.; Edwards, K.M.; Ward, M.M.; Colbert, R.A.; Sun, H.W.; Wood, G.M.; Barham, B.K.; Jones, A.; Aksentijevich, I.; Goldbach-Mansky, R.; Athreya, B.; Barron, K.S.; Kastner, D.L. Periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proc. Natl. Acad. Sci. USA, 2011, 108, 7148-7153.
22. Saadoun, D.; Wechser, B. Behcet's disease. Orphanet J. Rare Dis., 2012, 7, 20.
23. Touitou, I.; Magne, X.; Molinari, N.; Navarro, A.; Le Quellec, A.; Picco, P. MEFV mutations in Behcet's diseases. Hum. Mutat., 2000, 16, 271-272.
24. Atagundunz, P.; Ergun, T.; Direskeneli, H. MEFV mutations are increased in Behcet's disease and are associated with vascular involvment. Clin. Exp. Rheumatol., 2003, 21(Suppl30), S35-S37.
25. Petty, R.E.; Southwood, T.R.; Manners, P. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, edmonton, 2001. J. Rheumatol., 2004, 31(2), 390-392.
26. Pascual, V.; Allantaz, F.; Arce, E.; Punaro, M.; Banchereau, J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J. Exp. Med., 2005, 201, 1479-1486.
27. Masters, S.L.; Simon, Aksentijevich, I.; aastner, D.L. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Ann. Rev. Immunol., 2009, 27, 621-668.
28. Nepom, B.G.; Glass, D.N. Juvenile rheumatoid arthritis and HLA: report of the Park City III workshop. J. Rheumatol., 1992, 33, 70-74.
29. Verbsky, J.W.; White, A.J. Effective use of the recombinant interleukin 1 receptorantagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis. J. Rheumatol., 2004, 31, 2071-2075.
30. Yokota, S.; Miyamae, T.; Imagawa, T.; Iwata, N.; Katakura, S.; Mori, M.; Woo, P.; Nishimoto, N.; Yoshizaki, K.; Kishimoto, T. Therapeutic efficacy of humanizedrecombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum., 2005, 52, 818-825.
31. Frosch, M.; Roth, J. New insights in systemic juvenile idiopathic arthritis - from pathophysiology to treatment. Rheumatology (Oxford), 2008, 47, 121-125.
32. Rossi-Semerano, L.; Koné-Paut, I. Is Still's Disease an Autoinflammatory Syndrome? Int. J. Inflam., 2012, 2012, 480373.
33. Bywaters, E.G. Still's disease in the adult. Ann. Rheum. Dis., 1971, 30, 121-133.
34. Efthimiou, P.; Nandini Moorthy, L.; Mavragani, L.; Skokos, D.; Fautrel, B. Adult Onset Still's Disease and Autoinflammation. Int. J. Inflam., 2012, 2012, 964751.
35. Kalliolias, G.D.; Georgiou, P.E.; Antonopoulos, I.A.; Andonopoulosm A.P.; Liossis, S.N.C. Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial. Ann. Rheumatic Dis., 2007, 66(6), 842-843.
36. Efthimiou, P.; Georgy, S. Pathogenesis and management of adultonset Still's disease. Semin. Arthritis Rheum., 2006, 36, 144-152.
37. Ferrero-Miliani, L.; Nielsen, O.H.; Andersen, P.S. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1- generation. Clin. Exp. Immunol., 2007, 147(2), 227-235.
38. Asahina, A.; Sakurai, N.; Suzuki, Y.; Narushima, K. Schnitzler's syndrome with prominent neutrophil infiltration misdiagnosed as Sweet's syndrome: a typical example of urticarial neutrophilic dermatosis. Clin. Exp. Dermatol., 2010, 35(4), e123-e126.
39. Kieffer, C.; Cribier, B.; Lipsker, D. Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature. Medicine (Baltimore), 2009, 88(1), 23-31.
40. Pizzirani, C.; Falzoni, S.; Govoni, M.; La Corte, R.; Donadei, S.; Di Virgilio, F.; Trotta, F.; Lo Monaco, A. Dysfunctional inflammasome in Schnitzler's syndrome. Rheumatology (Oxford), 2009, 48(10), 1304-1308.
41. Migliorini, P.; Del Corso, I.; Tommasi, C.; Boraschi, D. Free circulating interleukin-18 is increased in the Schnitzler syndrome: a new autoinflammatory disease. Eur. Cytokine Netw., 2009, 20, 108-111.
42. Loock, J.; Lamprecht, P.; Timmann, C.; Mrowietz, U.; Csernok, E.; Gross, W.L. Genetic predisposition (NLRP3 V198M mutation) for IL-1-mediated inflammation in a patient with Schnitzler syndrome. J. Allergy Clin. Immunol., 2010, 125(2), 500-502.
43. Besada, E.; Nossent, H. Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler's syndrome: a case report and literature review. Clin. Rheumatol., 2010, 29, 567-571.
44. Schuster, C.; Kränke, B.; Aberer, E.; Arbab, E.; Sturm, G.; Aberer, W. Schnitzler syndrome: response to anakinra in two cases and review of the literature. Int. J. Dermatol., 2009, 48, 1190-1194.
45. Claes, K.; Bammens, B.; Delforge, M.; Evenepoel, P.; Kuypers, D.; Vanrenterghem, Y. Another devastating complication of the Schnitzler syndrome: AA amyloidosis. Br. J. Dermatol., 2008, 158(1), 182-184.
46. Lipsker, D. The Schnitzler syndrome. Orphanet J. Rare Dis., 2010, 5, 38.
47. Longhurst, H.J.; Yong, P.F.; Manson, A.L.; Cavenagh, J.D.; Grigoriadou, S.; Buckland, M.S. Mullins' syndrome: a new gammopathyrelated autoinflammatory syndrome resistant to anakinra. QJM., 2012, [Epub ahead of print] PMID: 23108029.
48. Sweet, R.D. An Acute Febrile Neutrophilic Dermatosis. Br. J. Dermatol., 1964, 76, 349-356.
49. Cohen, P.R. Sweet's syndrome - a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J. Rare Dis., 2007, 2, 34.
50. Kluger, N.; Gil-Bistes, D.; Guillot, B.; Bessis, D. Efficacy of antiinterleukin- 1 receptor antagonist anakinra (Kineret(R)) in a case of refractory Sweet's syndrome. Dermatology, 2011, 222(2), 123-127.
51. Ferguson, P.J. Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr. Rheumatol. Rep., 2012, 14(2), 130-141.
52. Tlougan, B.E.; Podjasek, J.O.; O'Haver, J.; Cordova, K.B.; Nguyen, X.H.; Tee, R.; Pinckard-Hansen, K.C.; Hansen, R.C. Chronic recurrent multifocal osteomyelitis (CRMO) and synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with associated neutrophilic dermatoses: a report of seven cases and review of the literature. Pediatr. Dermatol., 2009, 26(5), 497-505.
53. Schroder, K.; Zhou, R.; Tschopp, J. The NLRP3 inflammasome: a sensor for metabolic danger? Science, 2010, 327(5963), 296-300.
54. Martinon, F.; Petrilli, V.; Mayor, A.; Tardivel, A.; Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature, 2006, 440, 237-241.
55. Duewell, P.; Kono, H.; Rayner, K.J.; Sirois, C.M.; Vladimer, G.; Bauernfeind, F.G.; Abela, G.S.; Franchi, L.; Nuñez, G.; Schnurr, M.; Espevik, T.; Lien, E.; Fitzgerald, K.A.; Rock, K.L.; Moore, K.J.; Wright, S.D.; Hornung, V.; Latz, E. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature, 2010, 466(7306), 652.
56. Aslam, R.; Atindehou, M.; Lavaux, T.; Haïkel, Y.; Schneider, F.; Metz-Boutigue, M.H. Chromogranin A-derived peptides are involved in innate immunity. Curr. Med. Chem., 2012, 19(24), 4115-4123.